Effects of intraperitoneal cefazolin on mesothelial cells in noninfected CAPD patients.
School of Pharmacy, University of Missouri-Kansas City, USA. ManleyH@UMKC.edu
H J
HJ
Manley
G R
GR
Bailie
D000368:Aged; D018394:CA-125 Antigen / Q000032:analysis; D002437:Cefazolin / Q000493:pharmacokinetics* / Q000494:pharmacology; D002511:Cephalosporins / Q000493:pharmacokinetics* / Q000494:pharmacology; D004847:Epithelial Cells / Q000187:drug effects*; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D008297:Male; D008875:Middle Aged; D010529:Peritoneal Cavity / Q000166:cytology; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology
D018394:CA-125 Antigen; D002511:Cephalosporins; D002437:Cefazolin